Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.

Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data.

PURPOSE:To describe patterns of utilization, survival and infectious events in patients treated with rituximab at the University Hospital of Siena (UHS) to explore the feasibility of combining routinely collected administrative and hospital-pharmacy data for examining the real-world use of intraveno...

Detaylı Bibliyografya
Asıl Yazarlar:	Giuseppe Roberto, Andrea Spini, Claudia Bartolini, Valentino Moscatelli, Alessandro Barchielli, Davide Paoletti, Silvano Giorgi, Alberto Fabbri, Monica Bocchia, Sandra Donnini, Rosa Gini, Marina Ziche
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science (PLoS) 2020-01-01
Seri Bilgileri:	PLoS ONE
Online Erişim:	https://doi.org/10.1371/journal.pone.0229973

Benzer Materyaller

Validity of Italian administrative healthcare data in describing the real-world utilization of infusive antineoplastic drugs: the study case of rituximab use in patients treated at the University Hospital of Siena for onco-haematological indications
Yazar:: Claudia Bartolini, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry.
Yazar:: Andrea Spini, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Development and validation of a case-finding algorithm for the identification of non-small cell lung cancers in a region-wide Italian pathology registry
Yazar:: Andrea Spini, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies
Yazar:: Valerio Ciccone, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Yazar:: Davide Paoletti, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)

A BRAF-Negative Classic Hairy Cell Leukemia Patient with LongLasting Complete Remission after Rituximab and Pentostatin
Yazar:: Alessandro Gozzetti, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of β-Amyloid Precursor Protein in Cerebral Vasculature
Yazar:: Emma Ristori, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Togu na : the African Dogon "house of men, house of words" /
Yazar:: 267553 Spini, Tito
Baskı/Yayın Bilgisi: (1977)

Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing
Yazar:: Ginevra Nannelli, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Infusion reactions to rituximab administration: algorithm of management
Yazar:: D.D. Ivanov, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

California Pharmacists' and Pharmacy Technicians' Opinions on Administration of Immunizations in Community Pharmacies by Pharmacy Technicians
Yazar:: Paul Gavaza, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Dose Administration Aid Service in Community Pharmacies: Characterization and Impact Assessment
Yazar:: André Vicente, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Administration : the word and science /
Yazar:: 370131 Dunsire, Andrew
Baskı/Yayın Bilgisi: (1973)

Vaccine administration by pharmacy technicians: Impact on vaccination volume, pharmacy workflow and job satisfaction
Yazar:: Neil Kenneth Miran, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Yazar:: Yiyun Song, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Administration of monoclonal antibodies to b-lymphocytes (rituximab) in rheumatoid arthritis in Russia
Yazar:: E L Nasonov, ve diğerleri
Baskı/Yayın Bilgisi: (2008-08-01)

Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
Yazar:: Delgado Sánchez O, ve diğerleri
Baskı/Yayın Bilgisi: (2019-11-01)

Monitoring Endothelial and Tissue Responses to Cobalt Ferrite Nanoparticles and Hybrid Hydrogels.
Yazar:: Federica Finetti, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
Yazar:: Valerio Ciccone, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
Yazar:: Valerio Ciccone, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Rituximab Iodination Procedure for Radioiodinated Rituximab (131I-Rituximab) Preparation
Yazar:: Martalena Ramli, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

“We don’t have the words in Inuktitut”: Pharmacy translations in Nunavut, Canada
Yazar:: Sandra J. Romain
Baskı/Yayın Bilgisi: (2017-01-01)

Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
Yazar:: Dmytro Ivanov, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development
Yazar:: D. T. Klink, ve diğerleri
Baskı/Yayın Bilgisi: (2008-01-01)

Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis
Yazar:: Zachary S. Wallace, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

What's Past is Prologue: The History of the Discipline of Pharmacy Administration
Yazar:: Joseph K. Bonnarens
Baskı/Yayın Bilgisi: (2011-01-01)

Editorial: Social and Administrative Policy in Healthcare and Pharmacy Practice
Yazar:: Kingston Rajiah, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

What’s Past is Prologue: The History of the Discipline of Pharmacy Administration
Yazar:: Joseph K. Bonnarens, Ph.D.
Baskı/Yayın Bilgisi: (2011-01-01)

Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura
Yazar:: Francesco Zaja, ve diğerleri
Baskı/Yayın Bilgisi: (2008-06-01)

Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
Yazar:: Emanuele Cencini, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS
Yazar:: Thomas Osterholt, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
Yazar:: Safdar OY, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Stevens–Johnson syndrome secondary to rituximab administration in a chronic lymphocytic leukemia patient
Yazar:: V. Tomacinschii, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
Yazar:: Francesco Guzzi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Development of public administration of the health care system and pharmacy in Ukraine
Yazar:: М. М. Babenko
Baskı/Yayın Bilgisi: (2022-08-01)

Pharmacy practice in hospital settings in GCC countries: Dispensing and administration
Yazar:: Ahmed Y. Mayet, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Novel Integration of Administrative Pharmacy Residents in a Management Course
Yazar:: James Ford, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

“Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow
Yazar:: Paola Pacelli, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

The Role Of Word-Of-Mouth As A Moderator In Influencing The Adoption Of Online Pharmacy In Saudi Arabia
Yazar:: Abdullah Ali A, Alsadoun
Baskı/Yayın Bilgisi: (2022)

Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
Yazar:: Mikhail M. Kostik, ve diğerleri
Baskı/Yayın Bilgisi: (2016-08-01)